Cardurion Pharma, a developer of cardiovascular therapeutics, is dedicated to addressing cardiovascular diseases. The company's advanced and innovative therapeutics provide new treatment mechanisms for heart diseases that contribute to morbidity and mortality. This enables healthcare professionals to effectively prevent arrhythmia disorders and heart failures.

Investors Include:

Deepwork Capital, Digitalis Ventures, Bain Capital, Polaris Partners, Ascenta Capital, Farallon Capital Management, Millennium Management, Kenneth Novack, The Invus Group, Bain Capital Life Sciences, Takeda Pharmaceutical Company, Delos Capital Partners, GV, New Enterprise Associates, Delos Capital, DHS Ventures & Holdings, Fidelity Management & Research, Blue Owl Capital.

Own Cardurion Pharma stock or options?

Get an instant valuation

Completely free
100% confidential & secure
Takes less than a minute

What company do you own stock or options in?

How many shares or options do you own?

100% private & secure

Our available services for this company

Lifetime IncomeCharitable Remainder Trust

Tax SavingsDonor Advised Fund